You Might Like
AIDS Drug CEO Martin Shkreli Still Hasn’t Lowered Price As He Promised Two Weeks Ago
Two weeks after Turing CEO Martin Shkeli assured the world he would lower the price of his drug, nothing has actually changed, reports Tech Insider.
Last month, Shkeli provoked outrage when it was revealed he planned to dramatically raise the price of Daraprim, a drug that helps fight parasitic infections.
The drug rose from $13.50 to $750; a 5000% price hike.
Speaking to ABC News last month, he said, “We’ve agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit.”
Related: Greedy CEO Drops Price Of AIDS Drug, Pissed He’s Not Going To Make A Killing
So far, that’s yet to happen.
The price hasn’t gotten any higher in recent days, but it hasn’t gotten any lower, either.
A 30-day supply purchased at your nearest pharmacy would cost you $27,006; roughly $900 a pill.
Jeremy Kinser
You Might Like
